Clinical Trials Sponsored by Fate Therapeutics
Total 6413 results
-
Fate TherapeuticsRecruiting
-
Fate TherapeuticsTerminatedLymphoma, B-Cell | Chronic Lymphocytic LeukemiaUnited States
-
Fate TherapeuticsTerminatedSolid Tumor, AdultUnited States
-
Fate TherapeuticsWithdrawnFollicular Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Diffuse Large B Cell Lymphoma | Transformed Indolent Non-Hodgkin's Lymphoma
-
Fate TherapeuticsCompletedMelanoma | Lymphoma | Renal Cell Carcinoma | Cervical Cancer | Head and Neck Cancer | Small Cell Lung Cancer | Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | NSCLC | Advanced Solid Tumors | HER2-positive Breast Cancer | Pancreas Cancer | Urothelial Carcinoma | Merkel Cell Carcinoma | Microsatellite Instability and other conditionsUnited States
-
Fate TherapeuticsTerminatedHematological MalignancyUnited States
-
Fate TherapeuticsTerminatedMetabolic DisordersUnited States
-
Fate TherapeuticsTerminatedA Phase 1 Trial of a Single ProHema® CB Product for Pediatric Patients With Hematologic MalignanciesHematologic MalignanciesUnited States
-
Fate TherapeuticsRecruitingSystemic Lupus ErythematosusUnited States
-
Fate TherapeuticsRecruitingAdvanced Solid TumorUnited States
-
Fate TherapeuticsRecruitingLymphoma, B-Cell | Chronic Lymphocytic Leukemia | Precursor B-Cell Acute Lymphoblastic LeukemiaUnited States
-
Fate TherapeuticsTerminatedB-cell Lymphoma | Acute Myelogenous LeukemiaUnited States
-
Fate TherapeuticsTerminatedBreast Cancer | Head and Neck Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Non Small Cell Lung Cancer | GastroEsophageal CancerUnited States
-
Fate TherapeuticsCompletedAcute Myeloid Leukemia | Myelodysplastic Syndromes | Acute Lymphoblastic Leukemia | Chronic Myelogenous Leukemia | Hematologic Malignancies | Acute Graft-versus-host DiseaseUnited States
-
Fate TherapeuticsCompletedChronic Lymphocytic Leukemia (CLL) | Acute Lymphoblastic Leukemia (ALL) | Non-Hodgkin's Lymphoma (NHL) | Hodgkin's Disease | Acute Myelogenous Leukemia (AML)United States
-
Fate TherapeuticsRecruitingRelapsed/Refractory B-Cell LymphomaUnited States
-
Fate TherapeuticsTerminatedMelanoma | Lymphoma | Renal Cell Carcinoma | Cervical Cancer | Head and Neck Cancer | Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | NSCLC | Advanced Solid Tumor | Small-cell Lung Cancer | HER2-positive Breast Cancer | Pancreas Cancer | Urothelial Carcinoma | Merkel Cell Carcinoma | Microsatellite Instability and other conditionsUnited States
-
Fate TherapeuticsTerminatedSolid Tumor, AdultUnited States
-
Fate TherapeuticsTerminatedAcute Myeloid Leukemia | Multiple Myeloma | Myeloma | AML, AdultUnited States
-
Fate TherapeuticsTerminatedHematologic MalignanciesUnited States
-
Fate TherapeuticsCompletedMelanoma | Renal Cell Carcinoma | Hepatocellular Carcinoma | Colorectal Cancer | Pancreatic Cancer | Non Small Cell Lung Cancer | Advanced Solid Tumors | HER2-positive Breast Cancer | Head and Neck Squamous Cell Carcinoma | HER2 Positive Gastric Cancer | EGFR Positive Solid TumorUnited States
-
Fate TherapeuticsDana-Farber Cancer InstituteCompletedHematologic Malignancies | Allogeneic Stem Cell TransplantationUnited States
-
Can-Fite BioPharmaNot yet recruitingPancreatic Cancer | Pancreatic AdenocarcinomaIsrael
-
Can-Fite BioPharmaRecruitingNASH - Nonalcoholic SteatohepatitisIsrael, Bosnia and Herzegovina, Bulgaria, Moldova, Republic of, Romania, Serbia
-
Medi-Tate Ltd.Active, not recruitingBPHFrance, Italy, Germany, Australia, Spain, Switzerland
-
Gate Neurosciences, IncCompletedMajor Depressive DisorderUnited States
-
Can-Fite BioPharmaCompletedHepatocellular CarcinomaUnited States, Israel, Bulgaria, Romania, Serbia
-
Can-Fite BioPharmaCompletedOcular Hypertension | GlaucomaIsrael, Bulgaria
-
Can-Fite BioPharmaCompletedKeratoconjunctivitis SiccaIsrael
-
Can-Fite BioPharmaTerminatedRheumatoid ArthritisBosnia and Herzegovina, Canada, Israel, Moldova, Republic of, Poland, Romania, Serbia
-
Can-Fite BioPharmaCompletedRheumatoid ArthritisIsrael, Czechia, Bulgaria, Poland, Serbia, Ukraine
-
Tate & LyleBioFortisCompletedHypercholesterolemiaUnited States
-
Can-Fite BioPharmaCompletedRheumatoid ArthritisUnited States, Bulgaria, Israel, Poland, Romania, Serbia, Ukraine
-
Gate Neurosciences, IncCompleted
-
Gate Neurosciences, IncTerminatedMajor Depressive Disorder | Excessive SleepinessUnited States
-
Can-Fite BioPharmaCompleted
-
Can-Fite BioPharmaCompletedPlaque PsoriasisIsrael, Serbia, Romania, Croatia, Bosnia and Herzegovina, Bulgaria, Canada, Moldova, Republic of, Poland
-
Can-Fite BioPharmaCompletedRheumatoid ArthritisBulgaria, Israel
-
Can-Fite BioPharmaCompletedHepatocellular CarcinomaIsrael
-
Medi-Tate Ltd.CompletedBenign Prostatic Hyperplasia (BPH)Spain, Belgium, Italy, Switzerland, United Kingdom
-
Medi-Tate Ltd.Terminated
-
Can-Fite BioPharmaCompletedPlaque PsoriasisIsrael, United States, Bulgaria, Romania
-
Can-Fite BioPharmaCompletedNon-alcoholic Steatohepatitis (NASH)Israel
-
Medi-Tate Ltd.CompletedBenign Prostate Hyperplasia | Bladder Neck ObstructionIsrael
-
Can-Fite BioPharmaWithdrawnUveitis, Posterior | Uveitis, IntermediateIsrael
-
Can-Fite BioPharmaCompletedChronic Hepatitis CIsrael
-
Can-Fite BioPharmaRecruitingHepatocellular Carcinoma | CirrhosisUnited States, Bosnia and Herzegovina, Bulgaria, Israel, Moldova, Republic of, Poland, Romania, Serbia, Slovakia
-
Can-Fite BioPharmaCompleted
-
Gate Neurosciences, IncCompleted